Skip to main content
Top
Literature
2.
go back to reference Riordan CP, Scott RM (2018) Fourth ventricle stent placement for treatment of recurrent syringomyelia in patients with type I Chiari malformations. J Neurosurg: Pediatr 23(2):164–170PubMed Riordan CP, Scott RM (2018) Fourth ventricle stent placement for treatment of recurrent syringomyelia in patients with type I Chiari malformations. J Neurosurg: Pediatr 23(2):164–170PubMed
3.
go back to reference Soleman J, Bartoli A, Korn A, Constantini S, Roth J (2019) Treatment failure of syringomyelia associated with Chiari I malformation following foramen magnum decompression: how should we proceed? Neurosurg Rev 42(3):705–714CrossRefPubMed Soleman J, Bartoli A, Korn A, Constantini S, Roth J (2019) Treatment failure of syringomyelia associated with Chiari I malformation following foramen magnum decompression: how should we proceed? Neurosurg Rev 42(3):705–714CrossRefPubMed
4.
go back to reference Afshari FT, Solanki GA, Lo WB, Rodrigues D (2020) Posterior calvarial augmentation for Chiari malformation type 1 refractory to foramen magnum decompression. World Neurosurg 139:70–74CrossRefPubMed Afshari FT, Solanki GA, Lo WB, Rodrigues D (2020) Posterior calvarial augmentation for Chiari malformation type 1 refractory to foramen magnum decompression. World Neurosurg 139:70–74CrossRefPubMed
Metadata
Title
Letter to the editor regarding “fourth ventricle stent placement for treatment of type I Chiari malformation in children”
Authors
Fardad T. Afshari
Pasquale Gallo
Publication date
21-01-2023
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 2/2023
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-023-05847-x

Other articles of this Issue 2/2023

Child's Nervous System 2/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine